Finding investment opportunities in a bleak biotech stock market
The situation remains difficult in public markets as biotech stocks struggle to recover from a…
The situation remains difficult in public markets as biotech stocks struggle to recover from a…
As biotech investment slows following a record-breaking year, the Paris-based Sofinnova Partners has landed a…
The European life sciences venture capital firm Sofinnova Partners is celebrating its 50th birthday this…
The year 2021 is closing with a biotech investment rush as Eir Ventures, Apollo Health…
As this month’s COP26 United Nations climate summit highlighted the climate change emergency, venture capital…
Despite volatile biotech stocks limiting options for exit, Sofinnova Partners’ latest €472M fund highlights ballooning…
Biotech venture capital firms across Europe have warmly received the launch of a €235M (£200M)…
The French investor Sofinnova Partners has injected a total of €6M into three Italian gene…
Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was…
The public's response has been cautious after the European Union unveiled a pharmaceutical strategy last…
UK-based investment firm Medicxi aims to attract more investors to the life sciences with a…
European biotech companies are flocking to the Nasdaq Stock Market in 2020, but not all…